Drug metabolism

Medicine

Volumn 36, Issue 7, 2008, Pages 355-359

  Pirmohamed, Munir ^a  

^a UNIVERSITY OF LIVERPOOL   (United Kingdom)

Author keywords

bioactivation; cytochrome P450 enzymes; enzyme induction; enzyme inhibition; genetic polymorphisms; interactions; metabolism

Indexed keywords

ACYLTRANSFERASE; AMIODARONE; CARBAMAZEPINE; CERIVASTATIN; CHOLINESTERASE; CYCLOSPORIN A; CYTOCHROME P450; CYTOCHROME P450 2C19; CYTOCHROME P450 2C9; CYTOCHROME P450 2D6; CYTOCHROME P450 3A4; DIAZEPAM; DIHYDROPYRIMIDINE DEHYDROGENASE; DRUG; FLUTICASONE; GEMFIBROZIL; GLUCURONOSYLTRANSFERASE; GLUTATHIONE TRANSFERASE; HYPERICUM PERFORATUM EXTRACT; MEPHENYTOIN; ORAL CONTRACEPTIVE AGENT; PARACETAMOL; PHENYTOIN; PROTEINASE INHIBITOR; RIFAMPICIN; RITONAVIR; TERFENADINE; THIOPURINE METHYLTRANSFERASE; UNINDEXED DRUG; WARFARIN;

ADRENAL SUPPRESSION; BLEEDING; DRUG BLOOD LEVEL; DRUG EFFICACY; DRUG FATALITY; DRUG METABOLISM; DRUG USE; ENZYME INDUCTION; ENZYME MECHANISM; GENETIC VARIABILITY; GRAPEFRUIT JUICE; HARM REDUCTION; HUMAN; LIVER METABOLISM; LIVER TOXICITY; NEUROLOGIC DISEASE; PRIORITY JOURNAL; QT PROLONGATION; REVIEW; RHABDOMYOLYSIS; SEDATION; SIDE EFFECT; THROMBOSIS; TORSADE DES POINTES; TOXICOLOGY; TREATMENT OUTCOME;

EID: 46149127142     PISSN: 13573039     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mpmed.2008.04.002     Document Type: Review

References (15)

1. Park B.E., Pirmohamed M., and Kitteringham N.R. Role of drug disposition in drug hypersensitivity: a chemical, molecular, and clinical perspective. Chem Res Toxicol 11 (1998) 969-988
2. Nebert D.W., and Russell D.W. Clinical importance of the cytochromes P450. Lancet 360 (2002) 1155-1162
3. Delco F., Tchambaz L., Schlienger R., Drewe J., and Krahenbuhl S. Dose adjustment in patients with liver disease. Drug Saf 28 (2005) 529-545
4. Thummel K.E. Gut instincts: CYP3A4 and intestinal drug metabolism. J Clin Invest 117 (2007) 3173-3176
5. Baron J.M., Holler D., Schiffer R., et al. Expression of multiple cytochrome P450 enzymes and multidrug resistance-associated transport proteins in human skin keratinocytes. J Invest Derm 116 (2001) 541-548
6. Pirmohamed M., and Orme M.L.E. Drug interactions of clinical importance. In: Davies D.M., Ferner R.E., and de Glanville H. (Eds). Textbook of adverse drug reactions (1998), Chapman & Hall, London 888-912
7. Mannel M. Drug interactions with St John's wort: mechanisms and clinical implications. Drug Saf 27 (2004) 773-797
8. Ameer B., and Weintraub R.A. Drug interactions with grapefruit juice. Clin Pharmacokinet 33 (1997) 103-121
9. Pirmohamed M., James S., Meakin S., et al. Adverse drug reactions as cause of admission to hospital: prospective analysis of 18 820 patients. BMJ 329 (2004) 15-19
10. Pirmohamed M., and Park B.K. Cytochrome P450 enzyme polymorphisms and adverse drug reactions. Toxicology 192 (2003) 23-32
11. Ingelman-Sundberg M., Sim S.C., Gomez A., and Rodriguez-Antona C. Influence of cytochrome P450 polymorphisms on drug therapies: pharmacogenetic, pharmacoepigenetic and clinical aspects. Pharmacol Ther 116 (2007) 496-526
12. Borges S., Desta Z., Li L., et al. Quantitative effect of CYP2D6 genotype and inhibitors on tamoxifen metabolism: implication for optimization of breast cancer treatment. Clin Pharmacol Ther 80 (2006) 61-74
13. Innocenti F., and Ratain M.J. Pharmacogenetics of irinotecan: clinical perspectives on the utility of genotyping. Pharmacogenomics 7 (2006) 1211-1221
14. Park K., Williams D.P., Naisbitt D.J., Kitteringham N.R., and Pirmohamed M. Investigation of toxic metabolites during drug development. Toxicol Appl Pharmacol 207 suppl 2 (2005) 425-434
15. Larson A.M. Acetaminophen hepatotoxicity. Clin Liver Dis 11 (2007) 525-548